The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, ...

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...

Improving accessibility, affordability, and tailoring treatment and diagnostics to women's needs are some of the crucial measures to closing the health gap for the fairer sex by 2030, said experts at ...

Researchers at Nuclera completed the first Asian installations of its eProtein Discovery System at National Taiwan University ...

For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.

An editorial published in the New England Journal of Medicine 1 referred to the Photovoltaic Retina Implant Microarray (PRIMA) Implant (Science Corporation) as “the first treatment to restore vision” ...

SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.

New “AI GYM for Science” dramatically boosts the biological and chemical intelligence of any causal or frontier LLM, ...